Radiation, inflammation, and immune responses in cancer

Frontiers in Oncology

Volumn 2 JUN, Issue , 2012, Pages

  Multhoff, Gabriele ^a,b   Radons, Jürgen ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Multimmune GmbH   (Germany)

Author keywords

Heat shock proteins; HIF 1; Inflammation; NF B; PGHS 2; Radiation; Radioresistance; STAT 3

Indexed keywords

CELECOXIB; CURCUMIN; DOCOSAHEXAENOIC ACID; FIBROBLAST GROWTH FACTOR 2; FLUOROURACIL; GELATINASE B; GEMCITABINE; GOLNERMINOGENE PRADENOVEC; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MISMATCH REPAIR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NIVOCASAN; PITAVASTATIN; PROSTAGLANDIN SYNTHASE; PROTEIN MSH2; PROTEIN MSH6; PROTEIN TYROSINE PHOSPHATASE; SEX HORMONE; STAT PROTEIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

APOPTOSIS; CARCINOGENESIS; CELL SURVIVAL; CHEMORADIOTHERAPY; CHROMOSOMAL INSTABILITY; GENETIC STABILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; IONIZING RADIATION; NEOPLASM; PANCREAS CANCER; PATTERN RECOGNITION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; RADIATION; RADIOSENSITIVITY; REVIEW; TH17 CELL; UPREGULATION;

EID: 84875221247     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00058     Document Type: Review

References (214)

1. Abdel-Wahab, Z., Dar, M. M., Hester, D., Vervaert, C., Gangavalli, R., Barber, J., Darrow, T. L., and Seigler, H. F. (1996). Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells. Cell. Immunol. 171, 246-254.
2. Akashi, M., Hachiya, M., Koeffler, H. P., and Suzuki, G. (1992). Irradiation increases levels of GM-CSF through RNA stabilization which requires an AU-rich region in cancer cells. Biochem. Biophys. Res. Commun. 189, 986-993.
3. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
4. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
5. Albert, J. M., Kim, K. W., Cao, C., and Lu, B. (2006). Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol. Cancer Ther. 5, 1183-1189.
6. Antoon, J. W., White, M. D., Slaughter, E. M., Driver, J. L., Khalili, H. S., Elliott, S., Smith, C. D., Burow, M. E., and Beckman, B. S. (2011). Targeting NFκB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol. Ther. 11, 678-689.
7. Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., Yang, H., Amigorena, S., Ryffel, B., Barrat, F. J., Saftig, P., Levi, F., Lidereau, R., Nogues, C., Mira, J. P., Chompret, A., Joulin, V., Clavel-Chapelon, F., Bourhis, J., Andre, F., Delaloge, S., Tursz, T., Kroemer, G., and Zitvogel, L. (2007). Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13, 1050-1059.
8. Arends, J. E., Hoepelman, A. I., Nanlohy, N. M., Höppener, F. J., Hirsch, K. R., Park, J. G., and van Baarle, D. (2011). Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and-8 expression on peripheral CD4+ and CD8+ T-cells. Apoptosis 16, 959-966.
9. Arispe, N., and De Maio, A. (2000). ATP and ADP modulate a cation channel formed by Hsc70 in acidic phospholipid membranes. J. Biol. Chem. 275, 30839-30843.
10. Arispe, N., Doh, M., and De Maio, A. (2002). Lipid interaction differentiates the constitutive and stress-induced heat shock proteins Hsc70 and Hsp70. Cell Stress Chaperones 7, 330-338.
11. Asea, A., Kraeft, S. K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., and Calderwood, S. K. (2000). HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6, 435-442.
12. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., Stevenson, M. A., and Calderwood, S. K. (2002). Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034.
13. Aykin-Burns, N., Slane, B. G., Liu, A. T., Owens, K. M., O'Malley, M. S., Smith, B. J., Domann, F. E., and Spitz, D. R. (2011). Sensitivity to low-dose/low-LET ionizing radiation in mammalian cells harboring mutations in succinate dehydrogenase subunit C is governed by mitochondria-derived reactive oxygen species. Radiat. Res. 175, 150-158.
14. Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., and Kundu, T. K. (2004). Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163-51171.
15. Beatson, G. T. (1896a). On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2, 104-107.
16. Beatson, G. T. (1896b). On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2, 162-165.
17. Ben Baruch, A. (2006). Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 16, 38-52.
18. Ben-Neriah, Y., and Karin, M. (2011). Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715-723.
19. Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
20. Bisht, K. S., Bradbury, C. M., Mattson, D., Kaushal, A., Sowers, A., Markovina, S., Ortiz, K. L., Sieck, L. K., Isaacs, J. S., Brechbiel, M. W., Mitchell, J. B., Neckers, L. M., and Gius, D. (2003). Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res. 63, 8984-8995.
21. Brough, P. A., Aherne, W., Barril, X., Borgognoni, J., Boxall, K., Cansfield, J. E., Cheung, K. M., Collins, I., Davies, N. G., Drysdale, M. J., Dymock, B., Eccles, S. A., Finch, H., Fink, A., Hayes, A., Howes, R., Hubbard, R. E., James, K., Jordan, A. M., Lockie, A., Martins, V., Massey, A., Matthews, T. P., McDonald, E., Northfield, C. J., Pearl, L. H., Prodromou, C., Ray, S., Raynaud, F. I., Roughley, S. D., Sharp, S. Y., Surgenor, A., Walmsley, D. L., Webb, P., Wood, M., Workman, P., and Wright, L. (2008). 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. J. Med. Chem. 51, 196-218.
22. Cerella, C., Sobolewski, C., Dicato, M., and Diederich, M. (2010). Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochem. Pharmacol. 80, 1801-1815.
23. Chang, C. L., Marra, G., Chauhan, D. P., Ha, H. T., Chang, D. K., Ricciardiello, L., Randolph, A., Carethers, J. M., and Boland, C. R. (2002). Oxidative stress inactivates the human DNA mismatch repair system. Am. J. Physiol. Cell Physiol. 283, C148-C154.
24. Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., and Aggarwal, B. B. (2011). NF-κB addiction and its role in cancer: "one size does not fit all." Oncogene 30, 1615-1630.
25. Che, S. M., Zhang, X. Z., Hou, L., and Song, T. B. (2010). Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis. Cancer Invest. 28, 679-688.
26. Che, S. M., Zhang, X. Z., Liu, X. L., Chen, X., and Hou, L. (2011). The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells. Dis. Esophagus 24, 265-273.
27. Chen, J., Wang, J., Lin, L., He, L., Wu, Y., Zhang, L., Yi, Z., Chen, Y., Pang, X., and Liu, M. (2012a). Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol. Cancer Ther. 11, 277-287.
28. Chen, Z., Huang, C., Yang, Y. L., Ding, Y., Ou-Yang, H. Q., Zhang, Y. Y., and Xu, M. (2012b). Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells. Acta Pharmacol. Sin. 33, 101-108.
29. Chen, M. L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., and Khazaie, K. (2005). Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc. Natl. Acad. Sci. U.S.A. 102, 419-424.
30. Chendil, D., Ranga, R. S., Meigooni, D., Sathishkumar, S., and Ahmed, M. M. (2004). Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23, 1599-1607.
31. Cheng, J. C., Chou, C. H., Kuo, M. L., and Hsieh, C. Y. (2006). Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-κB signal transduction pathway. Oncogene 25, 7009-7018.
32. Cheng, S., Brzostek, S., Lee, S. R., Hollenberg, A. N., and Balk, S. P. (2002). Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol. 16, 1492-1501.
33. Cho, M. L., Kang, J. W., Moon, Y. M., Nam, H. J., Jhun, J. Y., Heo, S. B., Jin, H. T., Min, S. Y., Ju, J. H., Park, K. S., Cho, Y. G., Yoon, C. H., Park, S. H., Sung, Y. C., and Kim, H. Y. (2006). STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652-5661.
34. Ciernik, I. F., Romero, P., Berzofsky, J. A., and Carbone, D. P. (1999). Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope. Int. J. Radiat. Oncol. Biol. Phys. 45, 735-741.
35. Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A., and Olson, M. F. (2001). Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.
36. Colotta, F., Allavena, P., Sica, A., Garlanda, C., and Mantovani, A. (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081.
37. De Maio, A. (2011). Extracellular heat shock proteins, cellular export vesicles, and the stress observation system: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 16, 235-249.
38. Deorukhkar, A., and Krishnan, S. (2010). Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol. 80, 1904-1914.
39. Deorukhkar, A., Krishnan, S., Sethi, G., and Aggarwal, B. B. (2007). Back to basics: how natural products can provide the basis for new therapeutics. Expert. Opin. Investig. Drugs 16, 1753-1773.
40. Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., and Kurzrock, R. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14, 4491-4499.
41. Dittmann, K. H., Mayer, C., Ohneseit, P. A., Raju, U., Andratschke, N. H., Milas, L., and Rodemann, H. P. (2008). Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Int. J. Radiat. Oncol. Biol. Phys. 70, 203-212.
42. Divanovic, S., Trompette, A., Atabani, S. F., Madan, R., Golenbock, D. T., Visintin, A., Finberg, R. W., Tarakhovsky, A., Vogel, S. N., Belkaid, Y., Kurt-Jones, E. A., and Karp, C. L. (2005). Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6, 571-578.
43. Eder, C. (2009). Mechanisms of interleukin-1β release. Immunobiology 214, 543-553.
44. Endo, Y., Marusawa, H., Kou, T., Nakase, H., Fujii, S., Fujimori, T., Kinoshita, K., Honjo, T., and Chiba, T. (2008). Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 135, 889-898.
45. Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M., Rogers, A. B., Horwitz, B. H., and Fox, J. G. (2003). CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63, 6042-6050.
46. Fahy, B. N., Schlieman, M. G., Virudachalam, S., and Bold, R. J. (2004). Inhibition of AKT abrogates chemotherapy-induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer. J. Am. Coll. Surg. 198, 591-599.
47. Farkas, R., Pozsgai, E., Bellyei, S., Cseke, L., Szigeti, A., Vereczkei, A., Marton, S., Mangel, L., Horvath, O. P., and Papp, A. (2011). Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer. Anticancer Res. 31, 1769-1775.
48. Fedrigo, C. A., Grivicich, I., Schunemann, D. P., Chemale, I. M., dos, S. D., Jacovas, T., Boschetti, P. S., Jotz, G. P., Braga, F. A., and da Rocha, A. B. (2011). Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr. Radiat. Oncol. 6, 156.
49. Ferrarini, M., Heltai, S., Zocchi, M. R., and Rugarli, C. (1992). Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 51, 613-619.
50. Fugier-Vivier, I., de Bouteiller, O., Guret, C., Fossiez, F., Banchereau, J., Mattei, M. G., Ait-Yahia, S., Garcia, E., Lebecque, S., and Liu, Y. J. (1997). Molecular cloning of human RP105. Eur. J. Immunol. 27, 1824-1827.
51. Galabova-Kovacs, G., Kolbus, A., Matzen, D., Meissl, K., Piazzolla, D., Rubiolo, C., Steinitz, K., and Baccarini, M. (2006). ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle 5, 1514-1518.
52. Ganss, R., Ryschich, E., Klar, E., Arnold, B., and Hammerling, G. J. (2002). Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res. 62, 1462-1470.
53. Garcia-Pineres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., and Merfort, I. (2001). Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem. 276, 39713-39720.
54. Garg, A. K., Buchholz, T. A., and Aggarwal, B. B. (2005). Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 7, 1630-1647.
55. Gehrmann, M., Liebisch, G., Schmitz, G., Anderson, R., Steinem, C., De Maio, A., Pockley, G., and Multhoff, G. (2008). Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS ONE 3, e1925. doi:10.1371/journal.pone.0001925
56. Goldkorn, T., Balaban, N., Shannon, M., and Matsukuma, K. (1997). EGF receptor phosphorylation is affected by ionizing radiation. Biochim. Biophys. Acta 1358, 289-299.
57. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., and Weichselbaum, R. R. (1999). Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59, 3374-3378.
58. Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H. J., Schulte, T. W., Sausville, E., Neckers, L. M., and Toft, D. O. (1997). The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J. Biol. Chem. 272, 23843-23850.
59. Grimes, K. R., Warren, G. W., Fang, F., Xu, Y., and St. Clair, W. H. (2006). Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Oncol. Rep. 16, 771-776.
60. Grivennikov, S. I., and Karin, M. (2010). Inflammation and oncogenesis: a vicious connection. Curr. Opin. Genet. Dev. 20, 65-71.
61. Guttmann, D. M., and Koumenis, C. (2011). The heat shock proteins as targets for radiosensitization and chemosensitization in cancer. Cancer Biol. Ther. 12, 1023-1031.
62. Hadden, J. W. (2003). Immunodeficiency and cancer: prospects for correction. Int. Immunopharmacol. 3, 1061-1071.
63. Hakem, R. (2008). DNA-damage repair; the good, the bad, and the ugly. EMBO J. 27, 589-605.
64. Handrick, R., Ganswindt, U., Faltin, H., Goecke, B., Daniel, P. T., Budach, W., Belka, C., and Jendrossek, V. (2009). Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax. Radiother. Oncol. 90, 413-421.
65. Harada, H. (2011). How can we overcome tumor hypoxia in radiation therapy? J. Radiat. Res. 52, 545-556.
66. Harada, H., Itasaka, S., Kizaka-Kondoh, S., Shibuya, K., Morinibu, A., Shinomiya, K., and Hiraoka, M. (2009a). The Akt/mTOR pathway assures the synthesis of HIF-1a protein in a glucose-and reoxygenation-dependent manner in irradiated tumors. J. Biol. Chem. 284, 5332-5342.
67. Harada, H., Itasaka, S., Zhu, Y., Zeng, L., Xie, X., Morinibu, A., Shinomiya, K., and Hiraoka, M. (2009b). Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br. J. Cancer 100, 747-757.
68. Härdtner, C., Multhoff, G., Falk, W., and Radons, J. (2012). (-)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357. Eur. J. Pharmacol. 684, 36-43.
69. Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., and Aggarwal, B. B. (2009). Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 113, 2003-2013.
70. Henderson, I. C., and Canellos, G. P. (1980a). Cancer of the breast: the past decade (first of two parts). N. Engl. J. Med. 302, 17-30.
71. Henderson, I. C., and Canellos, G. P. (1980b). Cancer of the breast: the past decade (second of two parts). N. Engl. J. Med. 302, 78-90.
72. Hermens, A. F., and Barendsen, G. W. (1969). Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. Eur. J. Cancer 5, 173-189.
73. Hightower, L. E., and Guidon, P. T. Jr. (1989). Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell. Physiol. 138, 257-266.
74. Hodgson, M. C., Astapova, I., Cheng, S., Lee, L. J., Verhoeven, M. C., Choi, E., Balk, S. P., and Hollenberg, A. N. (2005). The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem. 280, 6511-6519.
75. Hong, J. H., Chiang, C. S., Sun, J. R., Withers, H. R., and McBride, W. H. (1997). Induction of c-fos and junB mRNA following in vivo brain irradiation. Brain Res. Mol. Brain Res. 48, 223-228.
76. Horvath, I., Multhoff, G., Sonnleitner, A., and Vigh, L. (2008). Membrane-associated stress proteins: more than simply chaperones. Biochim. Biophys. Acta 1778, 1653-1664.
77. Horvath, I., and Vigh, L. (2010). Cell biology: stability in times of stress. Nature 463, 436-438.
78. Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F. F., O'Sullivan, B., He, Z., Peng, Y., Tan, A. C., Zhou, L., Shen, J., Han, G., Wang, X. J., Thorburn, J., Thorburn, A., Jimeno, A., Raben, D., Bedford, J. S., and Li, C. Y. (2011). Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat. Med. 17, 860-866.
79. Huang, X. Z., Wang, J., Huang, C., Chen, Y. Y., Shi, G. Y., Hu, Q. S., and Yi, J. (2008). Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol. Ther. 7, 468-475.
80. Jänicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. (1998). Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
81. Johnson, G. E., Ivanov, V. N., and Hei, T. K. (2008). Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 13, 790-802.
82. Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J., and Neckers, L. (2003). IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17, 2115-2117.
83. Kaelin, W. G. Jr., and Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402.
84. Kao, G. D., Jiang, Z., Fernandes, A. M., Gupta, A. K., and Maity, A. (2007). Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J. Biol. Chem. 282, 21206-21212.
85. Karanjawala, Z. E., Murphy, N., Hinton, D. R., Hsieh, C. L., and Lieber, M. R. (2002). Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in DNA double-strand break repair mutants. Curr. Biol. 12, 397-402.
86. Karin, M. (2006). Nuclear factor-κB in cancer development and progression. Nature 441, 431-436.
87. Karin, M., Lawrence, T., and Nizet, V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823-835.
88. Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650.
89. Kim, K. W., Mutter, R. W., Cao, C., Albert, J. M., Shinohara, E. T., Sekhar, K. R., and Lu, B. (2006a). Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of survivin following irradiation. Mol. Cancer Ther. 5, 2659-2665.
90. Kim, R., Emi, M., Tanabe, K., and Arihiro, K. (2006b). Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 66, 5527-5536.
91. Kim, W. Y., Oh, S. H., Woo, J. K., Hong, W. K., and Lee, H. Y. (2009). Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1a. Cancer Res. 69, 1624-1632.
92. Koshiji, M., To, K. K., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., and Huang, L. E. (2005). HIF-1a induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol. Cell 17, 793-803.
93. Kuipers, G. K., Slotman, B. J., Wedekind, L. E., Stoter, T. R., Berg, J., Sminia, P., and Lafleur, M. V. (2007). Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. Int. J. Radiat. Biol. 83, 677-685.
94. Kundu, J. K., and Surh, Y. J. (2008). Inflammation: gearing the journey to cancer. Mutat. Res. 659, 15-30.
95. Kunnumakkara, A. B., Diagaradjane, P., Guha, S., Deorukhkar, A., Shentu, S., Aggarwal, B. B., and Krishnan, S. (2008). Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-κB-regulated gene products. Clin. Cancer Res. 14, 2128-2136.
96. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., and Oft, M. (2006). IL-23 promotes tumour incidence and growth. Nature 442, 461-465.
97. LeBlanc, H. N., and Ashkenazi, A. (2003). Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10, 66-75.
98. Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., and Semenza, G. L. (2009). Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc. Natl. Acad. Sci. U.S.A. 106, 17910-17915.
99. Li, F., and Sethi, G. (2010). Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy. Biochim. Biophys. Acta 1805, 167-180.
100. Lin, W. W., and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183.
101. Liu, J., Zhang, J., Wang, X., Li, Y., Chen, Y., Li, K., Zhang, J., Yao, L., and Guo, G. (2010). HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells. Exp. Cell Res. 316, 1985-1993.
102. Lopes, C. O., and Callera, F. (2011). Three-dimensional conformal radiotherapy in prostate cancer patients: rise in interleukin 6 (IL-6) but not IL-2, IL-4, IL-5, tumor necrosis factor-a, MIP-1-a, and LIF levels. Int. J. Radiat. Oncol. Biol. Phys. 82, 1385-1388.
103. Luster, A. D., Alon, R., and von Andrian, U. H. (2005). Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182-1190.
104. Magne, N., Toillon, R. A., Bottero, V., Didelot, C., Houtte, P. V., Gerard, J. P., and Peyron, J. F. (2006). NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett. 231, 158-168.
105. Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., Loda, M., Lane, H. A., and Sellers, W. R. (2004). mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10, 594-601.
106. Maloney, A., and Workman, P. (2002). HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert. Opin. Biol. Ther. 2, 3-24.
107. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., and Weaver, C. T. (2006). Transforming growth factor-β induces development of the T(H)17 lineage. Nature 441, 231-234.
108. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
109. Masiello, D., Cheng, S., Bubley, G. J., Lu, M. L., and Balk, S. P. (2002). Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J. Biol. Chem. 277, 26321-26326.
110. Matzinger, P. (1998). An innate sense of danger. Semin. Immunol. 10, 399-415.
111. Maziere, C., Conte, M. A., Leborgne, L., Levade, T., Hornebeck, W., Santus, R., and Maziere, J. C. (2001). UVA radiation stimulates ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem. Biophys. Res. Commun. 281, 289-294.
112. Meirovitz, A., Kuten, M., Billan, S., Abdah-Bortnyak, R., Sharon, A., Peretz, T., Sela, M., Schaffer, M., and Barak, V. (2010). Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer-a prospective pilot study. Radiat. Oncol. 5, 16.
113. Mencin, A., Kluwe, J., and Schwabe, R. F. (2009). Toll-like receptors as targets in chronic liver diseases. Gut 58, 704-720.
114. Mendonca, M. S., Chin-Sinex, H., Gomez-Millan, J., Datzman, N., Hardacre, M., Comerford, K., Nakshatri, H., Nye, M., Benjamin, L., Mehta, S., Patino, F., and Sweeney, C. (2007). Parthenolide sensitizes cells to X-ray-induced cell killing through inhibition of NF-kappaB and split-dose repair. Radiat. Res. 168, 689-697.
115. Meng, Y., Mauceri, H. J., Khodarev, N. N., Darga, T. E., Pitroda, S. P., Beckett, M. A., Kufe, D. W., and Weichselbaum, R. R. (2010). Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-β-dependent activation of antigen-specific CD8+ T cells. Mol. Ther. 18, 912-920.
116. Menssen, A., Epanchintsev, A., Lodygin, D., Rezaei, N., Jung, P., Verdoodt, B., Diebold, J., and Hermeking, H. (2007). c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability. Cell Cycle 6, 339-352.
117. Mills, K. D., Ferguson, D. O., and Alt, F. W. (2003). The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194, 77-95.
118. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K., and Kimoto, M. (1994). Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180, 1217-1224.
119. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T., and Kimoto, M. (1995). RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340.
120. Moeller, B. J., Cao, Y., Li, C. Y., and Dewhirst, M. W. (2004). Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5, 429-441.
121. Moeller, B. J., and Dewhirst, M. W. (2006). HIF-1 and tumour radiosensitivity. Br. J. Cancer 95, 1-5.
122. Moon, S. Y., Chang, H. W., Roh, J. L., Kim, G. C., Choi, S. H., Lee, S. W., Cho, K. J., Nam, S. Y., and Kim, S. Y. (2009). Using YC-1 to overcome the radioresistance of hypoxic cancer cells. Oral Oncol. 45, 915-919.
123. Moore, K. W., de Waal, M. R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
124. Moral, M. A., and Tomillero, A. (2008). Gateways to clinical trials. Methods Find. Exp. Clin. Pharmacol. 30, 149-171.
125. Multhoff, G. (2007). Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 43, 229-237.
126. Multhoff, G., Botzler, C., Wiesnet, M., Müller, E., Meier, T., Wilmanns, W., and Issels, R. D. (1995). A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int. J. Cancer 61, 272-279.
127. Multhoff, G., and Hightower, L. E. (1996). Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones 1, 167-176.
128. Multhoff, G., Molls, M., and Radons, J. (2012). Chronic inflammation in cancer development. Front. Immunol. 2:98. doi:10.3389/fimmu.2011.00098
129. Nakamura, J. L., Karlsson, A., Arvold, N. D., Gottschalk, A. R., Pieper, R. O., Stokoe, D., and Haas-Kogan, D. A. (2005). PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. J. Neurooncol. 71, 215-222.
130. Nakashima, M., Adachi, S., Yasuda, I., Yamauchi, T., Kawaguchi, J., Itani, M., Yoshioka, T., Matsushima-Nishiwaki, R., Hirose, Y., Kozawa, O., and Moriwaki, H. (2011). Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells. Cancer Lett. 313, 218-225.
131. Nambiar, D., Rajamani, P., and Singh, R. P. (2011). Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat. Res. 728, 139-157.
132. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., and Karin, M. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124.
133. Nickel, W., and Seedorf, M. (2008). Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 24, 287-308.
134. North, R. J. (1984). Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells. Cancer Immunol. Immunother. 16, 175-181.
135. Numasaki, M., Fukushi, J., Ono, M., Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D., Tahara, H., and Lotze, M. T. (2003). Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620-2627.
136. Obermann, W. M., Sondermann, H., Russo, A. A., Pavletich, N. P., and Hartl, F. U. (1998). In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143, 901-910.
137. Oblak, A., and Jerala, R. (2011). Toll-like receptor 4 activation in cancer progression and therapy. Clin. Dev. Immunol. 2011, 609579.
138. Ohto, U., Miyake, K., and Shimizu, T. (2011). Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family. J. Mol. Biol. 413, 815-825.
139. Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., and Aggarwal, B. B. (2007). Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-κB and NF-κB-regulated gene expression through direct inhibition of IκBa kinase β on cysteine 179 residue. J. Biol. Chem. 282, 17340-17350.
140. Pandey, M. K., Sung, B., Kunnumakkara, A. B., Sethi, G., Chaturvedi, M. M., and Aggarwal, B. B. (2008). Berberine modifies cysteine 179 of IκBa kinase, suppresses nuclear factor-κB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 68, 5370-5379.
141. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., and Dong, C. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141.
142. Pasi, F., Facoetti, A., and Nano, R. (2010). IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation. Anticancer Res. 30, 2769-2772.
143. Pfister, K., Radons, J., Busch, R., Tidball, J. G., Pfeifer, M., Freitag, L., Feldmann, H. J., Milani, V., Issels, R., and Multhoff, G. (2007). Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110, 926-935.
144. Pickering, M. T., and Kowalik, T. F. (2006). Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25, 746-755.
145. Plo, I., Nakatake, M., Malivert, L., de Villartay, J. P., Giraudier, S., Villeval, J. L., Wiesmuller, L., and Vainchenker, W. (2008). JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood 112, 1402-1412.
146. Pockley, A. G., and Multhoff, G. (2008). Cell stress proteins in extracellular fluids: friend or foe? Novartis Found. Symp. 291, 86-95.
147. Pockley, A. G., Muthana, M., and Calderwood, S. K. (2008). The dual immunoregulatory roles of stress proteins. Trends Biochem. Sci. 33, 71-79.
148. Prasad, S., Yadav, V. R., Sundaram, C., Reuter, S., Hema, P. S., Nair, M. S., Chaturvedi, M. M., and Aggarwal, B. B. (2010). Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway. J. Biol. Chem. 285, 26987-26997.
149. Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. (1997). Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 65-75.
150. Qiao, Q., Jiang, Y., and Li, G. (2012). Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma. Anticancer Drugs. doi:10.1097/CAD.0b013e3283503fbc. [Epub ahead of print].
151. Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., Sarkar, F. H., and Hillman, G. G. (2006). Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6, 107. doi:10.1186/1471-2407-6-107
152. Rajagopalan, H., Nowak, M. A., Vogelstein, B., and Lengauer, C. (2003). The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3, 695-701.
153. Raju, U., Ariga, H., Dittmann, K., Nakata, E., Ang, K. K., and Milas, L. (2005). Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib. Int. J. Radiat. Oncol. Biol. Phys. 63, 520-528.
154. Reissfelder, C., Timke, C., Schmitz-Winnenthal, H., Rahbari, N. N., Koch, M., Klug, F., Roeder, F., Edler, L., Debus, J., Buchler, M. W., Beckhove, P., Huber, P. E., and Weitz, J. (2011). A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer. BMC Cancer 11, 419. doi:10.1186/1471-2407-11-419
155. Rudner, J., Ruiner, C. E., Handrick, R., Eibl, H. J., Belka, C., and Jendrossek, V. (2010). The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation. Radiat. Oncol. 5, 108.
156. Sahin, E., Sahin, M., Sanlioglu, A. D., and Gumuslu, S. (2011). KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia. Int. J. Hyperthermia 27, 63-73.
157. Saintigny, Y., Dumay, A., Lambert, S., and Lopez, B. S. (2001). A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway. EMBO J. 20, 2596-2607.
158. Sandau, K. B., Faus, H. G., and Brune, B. (2000). Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 278, 263-267.
159. Sandur, S. K., Deorukhkar, A., Pandey, M. K., Pabon, A. M., Shentu, S., Guha, S., Aggarwal, B. B., and Krishnan, S. (2009). Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-κB activity. Int. J. Radiat. Oncol. Biol. Phys. 75, 534-542.
160. Schaue, D., and McBride, W. H. (2010). Links between innate immunity and normal tissue radiobiology. Radiat. Res. 173, 406-417.
161. Schildkopf, P., Frey, B., Ott, O. J., Rubner, Y., Multhoff, G., Sauer, R., Fietkau, R., and Gaipl, U. S. (2011). Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother. Oncol. 101, 109-115.
162. Schilling, D., Bayer, C., Emmerich, K., Molls, M., Vaupel, P., Huber, R. M., and Multhoff, G. (2012a). Basal HIF-1a expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther. Onkol. 188, 353-358.
163. Schilling, D., Bayer, C., Emmerich, K., Molls, M., Vaupel, P., Huber, R. M., and Multhoff, G. (2012b). Radiosensitization of normoxic and hypoxic H1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1a. PLoS ONE 7, e31110. doi:10.1371/journal.pone.0031110
164. Schilling, D., Gehrmann, M., Steinem, C., De Maio, A., Pockley, A. G., Abend, M., Molls, M., and Multhoff, G. (2009). Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J. 23, 2467-2477.
165. Sebbagh, M., Renvoize, C., Hamelin, J., Riche, N., Bertoglio, J., and Breard, J. (2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346-352.
166. Semenza, G. L. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8.
167. Shan, Y. X., Jin, S. Z., Liu, X. D., Liu, Y., and Liu, S. Z. (2007). Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat. Environ. Biophys. 46, 21-29.
168. Shang, Y., Myers, M., and Brown, M. (2002). Formation of the androgen receptor transcription complex. Mol. Cell 9, 601-610.
169. Shi, M., Guo, X. T., Shu, M. G., Chen, F. L., and Li, L. W. (2007). Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers. Med. Hypotheses 69, 33-35.
170. Shin, D. H., Kim, J. H., Jung, Y. J., Kim, K. E., Jeong, J. M., Chun, Y. S., and Park, J. W. (2007). Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Cancer Lett. 255, 107-116.
171. Singh, S., and Aggarwal, B. B. (1995). Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270, 24995-25000.
172. Singh, S., and Khar, A. (2006). Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med. Chem. 6, 259-270.
173. Singh-Gupta, V., Zhang, H., Banerjee, S., Kong, D., Raffoul, J. J., Sarkar, F. H., and Hillman, G. G. (2009). Radiation-induced HIF-1a cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int. J. Cancer 124, 1675-1684.
174. Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., Arber, N., Levin, B., Meinert, C. L., Martin, B., Pater, J. L., Goss, P. E., Lance, P., Obara, S., Chew, E. Y., Kim, J., Arndt, G., and Hawk, E. (2008). Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation 117, 2104-2113.
175. Son, E. W., Rhee, D. K., and Pyo, S. (2006). Gamma-irradiation-induced intercellular adhesion molecule-1 (ICAM-1) expression is associated with catalase: activation of Ap-1 and JNK. J. Toxicol. Environ. Health Part A 69, 2137-2155.
176. Son, P. S., Park, S. A., Na, H. K., Jue, D. M., Kim, S., and Surh, Y. J. (2010). Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-κB activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKKβ as a potential target. Carcinogenesis 31, 1442-1449.
177. Song, B., Song, W. G., Li, Z. J., Xu, Z. F., Wang, X. W., Wang, C. X., and Liu, J. (2012). Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem. Funct. 30, 11-17.
178. Srivastava, P. K. (1997). Cancer immunology. Methods 12, 115-116.
179. Stangl, S., Gehrmann, M., Riegger, J., Kuhs, K., Riederer, I., Sievert, W., Hube, K., Mocikat, R., Dressel, R., Kremmer, E., Pockley, A. G., Friedrich, L., Vigh, L., Skerra, A., and Multhoff, G. (2011). Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc. Natl. Acad. Sci. U.S.A. 108, 733-738.
180. Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., and Pavletich, N. P. (1997). Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89, 239-250.
181. Steinauer, K. K., Gibbs, I., Ning, S., French, J. N., Armstrong, J., and Knox, S. J. (2000). Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int. J. Radiat. Oncol. Biol. Phys. 48, 325-328.
182. Stephens, T. C., Currie, G. A., and Peacock, J. H. (1978). Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br. J. Cancer 38, 573-582.
183. Sun, Y., St. Clair, D. K., Fang, F., Warren, G. W., Rangnekar, V. M., Crooks, P. A., and St. Clair, W. H. (2007). The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Mol. Cancer Ther. 6, 2477-2486.
184. Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., and Aggarwal, B. B. (2008). Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis. Blood 111, 4880-4891.
185. Szumiel, I. (2008). Intrinsic radiation sensitivity: cellular signaling is the key. Radiat. Res. 169, 249-258.
186. Taba, K., Kuramitsu, Y., Ryozawa, S., Yoshida, K., Tanaka, T., Mori-Iwamoto, S., Maehara, S., Maehara, Y., Sakaida, I., and Nakamura, K. (2011). KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. Chemotherapy 57, 12-16.
187. Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., and Matsumoto, K. (2000). TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5, 649-658.
188. Tamatani, T., Azuma, M., Ashida, Y., Motegi, K., Takashima, R., Harada, K., Kawaguchi, S., and Sato, M. (2004). Enhanced radiosensitization and chemosensitization in NF-κB-suppressed human oral cancer cells via the inhibition of γ-irradiation-and 5-FU-induced production of IL-6 and IL-8. Int. J. Cancer 108, 912-921.
189. Tamatani, T., Azuma, M., Motegi, K., Takamaru, N., Kawashima, Y., and Bando, T. (2007). Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-κB activity in human oral squamous cell carcinoma cells. Int. J. Oncol. 31, 761-768.
190. Taplin, M. E., Manola, J., Oh, W. K., Kantoff, P. W., Bubley, G. J., Smith, M., Barb, D., Mantzoros, C., Gelmann, E. P., and Balk, S. P. (2008). A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones. BJU Int. 101, 1084-1089.
191. Timke, C., Winnenthal, H. S., Klug, F., Roeder, F. F., Bonertz, A., Reissfelder, C., Rochet, N., Koch, M., Tjaden, C., Buechler, M. W., Debus, J., Werner, J., Beckhove, P., Weitz, J., and Huber, P. E. (2011). Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. BMC Cancer 11, 134. doi:10.1186/1471-2407-11-134
192. Tomasini, R., Mak, T. W., and Melino, G. (2008). The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol. 18, 244-252.
193. Triantafilou, M., and Triantafilou, K. (2004). Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem. Soc. Trans. 32, 636-639.
194. Trinchieri, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146.
195. Tsuboi, Y., Kurimoto, M., Nagai, S., Hayakawa, Y., Kamiyama, H., Hayashi, N., Kitajima, I., and Endo, S. (2009). Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-kappa B activation in human glioma cell lines. J. Neurosurg. 110, 594-604.
196. Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., and Wahl, G. M. (2002). c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell 9, 1031-1044.
197. Valerie, K., Yacoub, A., Hagan, M. P., Curiel, D. T., Fisher, P. B., Grant, S., and Dent, P. (2007). Radiation-induced cell signaling: inside-out and outside-in. Mol. Cancer Ther. 6, 789-801.
198. Veeraraghavan, J., Natarajan, M., Aravindan, S., Herman, T. S., and Aravindan, N. (2011a). Radiation-triggered tumor necrosis factor (TNF) a-NFκB cross-signaling favors survival advantage in human neuroblastoma cells. J. Biol. Chem. 286, 21588-21600.
199. Veeraraghavan, J., Natarajan, M., Lagisetty, P., Awasthi, V., Herman, T. S., and Aravindan, N. (2011b). Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas 40, 1107-1119.
200. Vega, V. L., Rodriguez-Silva, M., Frey, T., Gehrmann, M., Diaz, J. C., Steinem, C., Multhoff, G., Arispe, N., and De Maio, A. (2008). Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J. Immunol. 180, 4299-4307.
201. Wang, C. Y., Mayo, M. W., and Baldwin, A. S. Jr. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
202. Wang, L., Fu, J. N., Wang, J. Y., Jin, C. J., Ren, X. Y., Tan, Q., Li, J., Yin, H. W., Xiong, K., Wang, T. Y., Liu, X. M., and Zeng, H. H. (2011). Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy. Anticancer Drugs 22, 732-740.
203. Wang, X. S., Shi, Q., Williams, L. A., Mao, L., Cleeland, C. S., Komaki, R. R., Mobley, G. M., and Liao, Z. (2010). Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav. Immun. 24, 968-974.
204. Wheeler, D. S., Chase, M. A., Senft, A. P., Poynter, S. E., Wong, H. R., and Page, K. (2009). Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir. Res. 10, 31.
205. Wong, C. C., Zhang, H., Gilkes, D. M., Chen, J., Wei, H., Chaturvedi, P., Hubbi, M. E., and Semenza, G. L. (2012). Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J. Mol. Med. doi:10.1007/s00109-011-0855-y. [Epub ahead of print].
206. Yamaguchi, T., and Sakaguchi, S. (2006). Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 16, 115-123.
207. Yang, C. M., Lee, I. T., Lin, C. C., Yang, Y. L., Luo, S. F., Kou, Y. R., and Hsiao, L. D. (2009). Cigarette smoke extract induces COX-2 expression via a PKCa/c-Src/EGFR, PDGFR/PI3K/Akt/NF-κB pathway and p300 in tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L892-L902.
208. Yoon, H. G., and Wong, J. (2006). The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist-and antagonist-regulated transcription by androgen receptor. Mol. Endocrinol. 20, 1048-1060.
209. Zand, H., Rahimipour, A., Salimi, S., and Shafiee, S. M. (2008). Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-γ activation and NF-κB suppression. Mol. Cell. Biochem. 317, 113-120.
210. Zeng, L., Ou, G., Itasaka, S., Harada, H., Xie, X., Shibuya, K., Kizaka-Kondoh, S., Morinibu, A., Shinomiya, K., and Hiraoka, M. (2008). TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis. Cancer Sci. 99, 2327-2335.
211. Zhang, J. S., Nakatsugawa, S., Niwa, O., Ju, G. Z., and Liu, S. Z. (1994). Ionizing radiation-induced IL-1 alpha, IL-6 and GM-CSF production by human lung cancer cells. Chin. Med. J. 107, 653-657.
212. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W., and Semenza, G. L. (2000). Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.
213. Zhou, D., Yu, T., Chen, G., Brown, S. A., Yu, Z., Mattson, M. P., and Thompson, J. S. (2001). Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivo. Int. J. Radiat. Biol. 77, 763-772.
214. Zhu, P., Baek, S. H., Bourk, E. M., Ohgi, K. A., Garcia-Bassets, I., Sanjo, H., Akira, S., Kotol, P. F., Glass, C. K., Rosenfeld, M. G., and Rose, D. W. (2006). Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124, 615-629.